J&J Buys $440 Mil. Stake In Crucell; Will Collaborate On Universal Flu Vaccine
J&J follows its brethren into vaccines, and Crucell lands a big-pharma partner in the wake of its failed deal with Wyeth.
J&J follows its brethren into vaccines, and Crucell lands a big-pharma partner in the wake of its failed deal with Wyeth.